6th Edition of Global Conference on
Addiction Medicine, Behavioral Health and Psychiatry
October 20-22, 2025 | Orlando, Florida, USA
Major Depressive Disorder and Treatment Innovations
With increasing rates of depression worldwide, clinicians are rethinking traditional treatment frameworks by integrating major depressive disorder and treatment innovations into routine psychiatric care. New approaches such as esketamine nasal spray, deep brain stimulation, and digital therapeutics are reshaping how depression is addressed, particularly in treatment-resistant populations. Psychotherapies like cognitive control training and acceptance-based strategies are also showing promising results. Combining neurobiological insights with technology, clinicians can now predict treatment response with greater accuracy, minimizing trial-and-error prescribing. This precision model supports faster recovery and fewer relapses. Emphasizing patient-centered care, new innovations allow for better symptom tracking, greater adherence, and reduced long-term impact on daily functioning.
Nile Stanley
University of North Florida, United States
Ann Marie Leonard Zabel
Curry College, United States
Denis Larrivee
University of Navarra, Spain
Scharbach Hugues
Paris University, France
Alphonsus Obayuwana
Triple-H Project LLC, United States
Malasri Chaudhery Malgeri
Recovery com, United States
Jana Furstova
Palacký University Olomouc, Czech RepublicSubmit your abstract Today
Title : Tailoring biblio-poetry therapies using AI and biofeedback for addiction treatment
Nile Stanley, University of North Florida, United States
Title : The A-B-C of happiness coaching
Alphonsus Obayuwana, Triple-H Project LLC, United States
Title : Clinical pharmacology of marijuana: Update 2024
Frederick J Goldstein, Philadelphia College of Osteopathic Medicine, United States
Title : Trait-based recovery: Evidence-based trait activation to reduce depression, anxiety, and improve client engagement in addiction treatment
Jason Glenn Roop, The Center for Trait-Based Transformation, United States
Title : An investigation of the factors responsible for ubstance abuse from a cognitive perspective based on a mixed method approach
Adewole Olukorede, Literary Edifice, Italy
Title : A Long-Acting Naltrexone Implant (for Opioid Use Disorder: First-in-Human Phase I Trial)
Steven M Cohen, Akyso Therapeutics, United States